J. D. Elliott

发表

Upgrade refinery residuals into value-added products

M. Kovac, G. Movik, J. D. Elliott, 2006 .

Sensor uncertainty management for an encapsulated logical device architecture. Part II: a control policy for sensor uncertainty

Elizabeth A. Croft, J. D. Elliott, D. Langlois, 2001, Proceedings of the 2001 American Control Conference. (Cat. No.01CH37148).

Optimize coker operations : Refinning developments

J. D. Elliott, 2003 .

A systematic approach to automation workcell design: the encapsulated logical device architecture

Elizabeth A. Croft, J. D. Elliott, D. Langlois, 2001, Conference Documentation International Conference on Multisensor Fusion and Integration for Intelligent Systems. MFI 2001 (Cat. No.01TH8590).

Sensor uncertainty management for an encapsulated logical device architecture: Part I - fusion of uncertain sensor data

Elizabeth A. Croft, J. D. Elliott, D. Langlois, 2001, Proceedings of the 2001 American Control Conference. (Cat. No.01CH37148).

Delayed coking innovations and new design trend

J. D. Elliott, 1999 .

Drug discovery in the next millennium.

J. D. Elliott, R. Ruffolo, E. Ohlstein, 2000, Annual review of pharmacology and toxicology.

Discovery of Tertiary Amine and Indole Derivatives as Potent RORγt Inverse Agonists.

J. D. Elliott, Yonghui Wang, Zhijun Xiang, 2014, ACS medicinal chemistry letters.

Pyridine-derived γ-secretase modulators.

J. D. Elliott, Zehong Wan, Wei Zhao, 2011, Bioorganic & medicinal chemistry letters.

Trigeminal nerve ganglion stimulation‐induced neurovascular reflexes in the anaesthetized cat: Role of endothelinB receptors in carotid vasodilatation

J. D. Elliott, N. Aiyar, A. A. Parsons, 1999, British journal of pharmacology.

Asymmetric synthesis via acetal templates. 9. Further studies of the allylation reaction. Preparation of (−)-dihydromyoporone

J. D. Elliott, S. Natarajan, S. Lindell, 1984 .

Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295.

J. D. Elliott, Nicholas D. Adams, X. Qian, 2010, ACS medicinal chemistry letters.

Pharmacological evidence for the presence of three distinct functional endothelin receptor subtypes in the rabbit lateral saphenous vein

J. D. Elliott, S. Douglas, E. Ohlstein, 1995, British journal of pharmacology.

A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670.

J. D. Elliott, S. Douglas, G. Feuerstein, 1994, Circulation research.

Endothelin and Cardiovascular Function

J. D. Elliott, D. Brooks, E. Ohlstein, 1998 .

Regional vasodilation to endothelin-1 is mediated by a non-ETA receptor subtype in the anaesthetized rat: effect of BQ-123 on systemic haemodynamic responses.

J. D. Elliott, S. Douglas, E. Ohlstein, 1992, European journal of pharmacology.

Inhibition of 3-hydroxy-3-methylglutaryl coenzyme A synthase by antibiotic 1233A and other beta-lactones.

J. D. Elliott, R. Mayer, M. Fisher, 1990, Biochemical and biophysical research communications.

The Endothelin Receptor Antagonist SB 217242 Reduces Cerebral Focal Ischemic Brain Injury

J. D. Elliott, F. Barone, G. Feuerstein, 1995, Journal of cardiovascular pharmacology.

Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670.

J. D. Elliott, S. Douglas, R. Ruffolo, 1994, The Journal of pharmacology and experimental therapeutics.

The selective endothelin ETA receptor antagonist BQ123 antagonizes endothelin-1-mediated mitogenesis.

J. D. Elliott, E. Ohlstein, C. Sung, 1992, European journal of pharmacology.

Chapter 9. Endothelin Antagonists

J. D. Elliott, J. Luengo, C. E. Peishoff, 1996 .

Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptor.

J. D. Elliott, D. Veber, R. Hertzberg, 2004, Journal of medicinal chemistry.

California dreamin' 'bout endothelin: emerging new therapeutics.

J. D. Elliott, T. Warner, E. Ohlstein, 1996, Trends in pharmacological sciences.

Endothelin receptors: Receptor classification, novel receptor antagonists, and potential therapeutic targets

J. D. Elliott, G. Feuerstein, E. Ohlstein, 1996, Medicinal research reviews.

Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders.

J. D. Elliott, Wei Zhang, Yan Xu, 2016, ACS medicinal chemistry letters.

Indole-propionic acid derivatives as potent, S1P3-sparing and EAE efficacious sphingosine-1-phosphate 1 (S1P1) receptor agonists.

J. D. Elliott, Wei Zhang, Yan Xu, 2012, Bioorganic & medicinal chemistry letters.

A novel series of ETA selective antagonists

J. D. Elliott, E. Ohlstein, P. Nambi, 2002 .

An efficient approach to the synthesis of 1,3-diaryl-1,2,3,4-[4H]-tetrahydronaphthalene-2-carboxylic acids.

J. D. Elliott, E. Ohlstein, P. Nambi, 1998, Bioorganic & medicinal chemistry.

N,N'-Diarylcyanoguanidines as antagonists of the CXCR2 and CXCR1 chemokine receptors.

J. D. Elliott, Wei-Chang Fu, H. Sarau, 2006, Bioorganic & medicinal chemistry letters.

Discovery of potent and orally bioavailable N,N'-diarylurea antagonists for the CXCR2 chemokine receptor.

J. D. Elliott, K. Ward, H. Sarau, 2004, Bioorganic & medicinal chemistry letters.

Nonpeptide endothelin receptor antagonists. V: Prevention and reversal of acute renal failure in the rat by SB 209670.

J. D. Elliott, D. Brooks, E. Ohlstein, 1995, The Journal of pharmacology and experimental therapeutics.

Pharmacologic characterization of the novel, orally available endothelin-A--selective antagonist SB 247083.

J. D. Elliott, J. Luengo, S. Douglas, 1998, Journal of cardiovascular pharmacology.

Asymmetric synthesis via acetal templates. 6. A stereoselective approach to a key intermediate for the preparation of vitamin D metabolites

J. D. Elliott, G. Hanson, W. S. Johnson, 1984 .

Asymmetric synthesis via acetal templates. 4. Reactions with silylacetylenic compounds. Formation of chiral propargylic alcohols

J. D. Elliott, W. S. Johnson, R. Elliott, 1983 .

A catalyst-free N–H insertion/Mannich-type reaction cascade of α-nitrodiazoesters

J. D. Elliott, Xichen Lin, Ting Yang, 2013 .

Endothelin-converting enzyme: substrate specificity and inhibition by novel analogs of phosphoramidon.

J. D. Elliott, C. Lee, P. Keller, 1996, Biochemical and biophysical research communications.

A mild and efficient carboxylate-directed C–H arylation of aryl carboxylic acids with iodobenzenes in water

J. D. Elliott, Xichen Lin, Ting Yang, 2015 .

Enantioselective routes to protected syn- and anti-.beta.-phenylcysteines

J. D. Elliott, J. Samanen, M. A. Lago, 1992 .

Asymmetric synthesis via acetal templates. 3. On the stereochemistry observed in the cyclization of chiral acetals of polyolefinic aldehydes; formation of optically active homoallylic alcohols

J. D. Elliott, P. Bartlett, W. S. Johnson, 1983 .

Asymmetric synthesis via chiral acetal templates. 8. Reactions with organometallic reagents

J. D. Elliott, S. Lindell, W. S. Johnson, 1985 .

Asymmetric synthesis via acetal templates. 15. The preparation of enantiomerically pure mevinolin analogs

J. D. Elliott, W. S. Johnson, A. Kelson, 1988 .

Asymmetric Synthesis via Acetal Templates. 14.1 Preparation of Enantiomerically Pure (3S,4S)- and (3S,4R)-Statine Derivatives

J. D. Elliott, W. S. Johnson, R. Conrow, 1987 .

Asymmetric synthesis via acetal templates. 12. Highly diastereoselective coupling reactions with a ketene acetal. An efficient, asymmetric synthesis of R-(+)-α-lipoic acid☆

J. D. Elliott, J. Steele, W. S. Johnson, 1985 .

Asymmetric synthesis via chiral acetal templates. 7. Further studies on the cyanation reaction. The use of acetals derived from diols with one chiral center

J. D. Elliott, W. S. Johnson, V. M. Choi, 1984 .

1,3-Diarylindan-2-carboxylic acids, potent and selective non-peptide endothelin receptor antagonists.

J. D. Elliott, N. Elshourbagy, K. Erhard, 1994, Journal of medicinal chemistry.

2-Aminopyrimidin-4(1H)-one as the novel bioisostere of urea: discovery of novel and potent CXCR2 antagonists.

J. D. Elliott, Wei Zhang, Xichen Lin, 2014, Bioorganic & medicinal chemistry letters.

Asymmetric synthesis via acetal templates. 13. Preparation of aldol compounds from butane-1,3-diol acetals

J. D. Elliott, W. S. Johnson, Claire Edington, 1987 .

Asymmetric synthesis via chiral acetal templates. 7. Further studies on the cyanation reaction. The use of acetals derived from diols with one chiral center

J. D. Elliott, W. S. Johnson, V. M. Choi, 1984 .

A Catalyst‐Free N—H Insertion/Mannich‐Type Reaction Cascade of α‐Nitrodiazoesters.

J. D. Elliott, Xichen Lin, Ting Yang, 2013 .

Asymmetric synthesis via acetal templates. 5. Reactions with cyanotrimethylsilane. Enantioselective preparation of cyanohydrins and derivatives

J. D. Elliott, W. S. Johnson, V. M. Choi, 1983 .

Correction: Slow binding inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase [Erratum to document cited in CA112(23):212921g]

J. D. Elliott, C. E. Peishoff, R. Mayer, 1990 .

Synthesis and properties of a series of sterically hindered guanidine bases

J. D. Elliott, D. Barton, S. Gero, 1982 .

In vivo pharmacological characterization of the non‐peptide endothelin receptor antagonist SB 209670

J. D. Elliott, S. Douglas, E. Ohlstein, 1995, British journal of pharmacology.

Nonpeptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human endothelinA and endothelinB receptors.

J. D. Elliott, H. Wu, N. Elshourbagy, 1994, The Journal of pharmacology and experimental therapeutics.

Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogs.

J. D. Elliott, R. Ruffolo, D. Brooks, 1994, The Journal of pharmacology and experimental therapeutics.

Superficial stromal reactions of lower genital tract.

J. D. Elliott, G. Elliott, 1973, Archives of pathology.

Pharmacologic Evidence for the Presence of Three Functional Endothelin Receptor Subtypes in Rabbit Saphenous Vein

J. D. Elliott, S. Douglas, E. Ohlstein, 1995, Journal of cardiovascular pharmacology.

The synthesis of novel bridged A ring steroids

J. D. Elliott, D. Holt, H. Lan-Hargest, 1987 .

Antihypertensive actions of the novel nonpeptide endothelin receptor antagonist SB 209670.

J. D. Elliott, S. Douglas, G. Feuerstein, 1995, Hypertension.

Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonist.

J. D. Elliott, J. Luengo, D. Brooks, 1998, The Journal of pharmacology and experimental therapeutics.

SB 234551, a novel endothelin--A receptor antagonist, unmasks endothelin-induced renal vasodilatation in the dog.

J. D. Elliott, D. Brooks, E. Ohlstein, 1998, Journal of cardiovascular pharmacology.

Novel complex crystal structure of prolyl hydroxylase domain-containing protein 2 (PHD2): 2,8-Diazaspiro[4.5]decan-1-ones as potent, orally bioavailable PHD2 inhibitors.

J. D. Elliott, Wei Zhang, Xichen Lin, 2013, Bioorganic & medicinal chemistry.

Convenient preparations of di-t-butyl and methyl t-butyl iminodicarboxylates. The use of methyl t-butyl iminodicarboxylate potassium salt as a modified Gabriel reagent

J. D. Elliott, J. H. Jones, Christopher T. Clarke, 1978 .

t-Butyl methyl iminodicarboxylate potassium salt: a modified Gabriel reagent for the introduction of t-butoxycarbonylamino groups

J. D. Elliott, J. H. Jones, 1977 .

Syntheses of (±)- and (−)-pentenomycin I

J. D. Elliott, R. J. Stoodley, M. Hetmanski, 1983 .

New Strategies in Drug Discovery

J. D. Elliott, Eliot H Ohlstein, Anthony G Johnson, 2006, Methods in molecular biology.

Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors.

J. D. Elliott, Yonghui Wang, Zhijun Xiang, 2015, ACS medicinal chemistry letters.

Prediction of the Intestinal Absorption of Endothelin Receptor Antagonists Using Three Theoretical Methods of Increasing Complexity

J. D. Elliott, Kristina Luthman, Harma Ellens, 1999, Pharmaceutical Research.

Discovery of novel 1,2,4-thiadiazole derivatives as potent, orally active agonists of sphingosine 1-phosphate receptor subtype 1 (S1P(1)).

J. D. Elliott, Wei Zhang, Xichen Lin, 2012, Journal of medicinal chemistry.

The hyaloid vessel and physiologic optic cup.

J. D. Elliott, G. Elliott, 1973, Microvascular Research.

The synthesis and properties of a series of strong but hindered organic bases

J. D. Elliott, D. Barton, S. Gero, 1982 .

Perinatal effect of magnesium sulfate administered for tocolysis

J. D. Elliott, T. Garite, R. Clark, 2003 .

Molecular Biology of the Endothelin Receptors

J. D. Elliott, C. E. Peishoff, Jonathan A. Lee, 1998 .

In vitro permeability screening for identification of orally bioavailable endothelin receptor antagonists

J. D. Elliott, Hung‐Yuan Cheng, E. Ohlstein, 1997 .

Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent RORγt inhibitors.

J. D. Elliott, Wei Zhang, Yonghui Wang, 2014, Bioorganic & medicinal chemistry.

The photochemical rearrangement of a steroidal dienol triflate

J. D. Elliott, H. Lan-Hargest, B. Metcalf, 1987 .

Slow binding inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

J. D. Elliott, C. E. Peishoff, R. Mayer, 1990, Biochemistry.

Endothelin Receptor Subtypes in the Pathogenesis of Angioplasty‐Induced Neointima Formation in the Rat: A Comparison of Selective ETA Receptor Antagonism and Dual ETA/ETB Receptor Antagonism Using BQ‐123 and SB 209670

J. D. Elliott, S. Douglas, E. Ohlstein, 1995, Journal of cardiovascular pharmacology.

Discovery of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists.

J. D. Elliott, Wei Zhang, Yonghui Wang, 2015, Bioorganic & medicinal chemistry.

Discovery of thiadiazole amides as potent, S1P₃-sparing agonists of sphingosine-1-phosphate 1 (S1P₁) receptor.

J. D. Elliott, Wei Zhang, Yonghui Wang, 2012, Bioorganic & medicinal chemistry letters.

Tyr-129 is important to the peptide ligand affinity and selectivity of human endothelin type A receptor.

J. D. Elliott, C. E. Peishoff, E. Ohlstein, 1994, Proceedings of the National Academy of Sciences of the United States of America.

J. D. Elliott, R. J. Stoodley, M. Hetmanski, 1981 .

Discovery of thiadiazole amides as potent, S1P₃-sparing agonists of sphingosine-1-phosphate 1 (S1P₁) receptor.

J. D. Elliott, Wei Zhang, Yonghui Wang, 2012, Bioorganic & medicinal chemistry letters.

Plasma- and cerebrospinal fluid-immunoreactive endothelin-1: effects of nonpeptide endothelin receptor antagonists with diverse affinity profiles for endothelin-A and endothelin-B receptors.

J. D. Elliott, J. Luengo, R. Willette, 1998, Journal of cardiovascular pharmacology.

The preparation of 9-alkylthiofluorenes from biphenyl-2-carboxaldehydes

J. D. Elliott, J. Leber, 1989 .

Endothelin receptors: Receptor classification, novel receptor antagonists, and potential therapeutic targets

J. D. Elliott, G. Feuerstein, E. Ohlstein, 1996, Medicinal research reviews.